Clinical risk factors for ischemic complications after percutaneous coronary interventions: Results from the EPIC trial

American Heart Journal

Volumn 137, Issue 2, 1999, Pages 264-273

  Thel, Mark C ^b   Califf, Robert M ^a   Tcheng, James E ^b   Sigmon, Kristina N ^b   Lincoff, A Michael ^b   Topol, Eric J ^b   Ellis, Stephen G ^b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RACE DIFFERENCE; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0032908358     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1053/hj.1999.v137.92521     Document Type: Article

References (32)

1. 1. Dorros G, Cowley MJ, Janke L, Kelsey SF, Mullin SM, Van Raden M. In-hospital mortality rate in the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Am J Cardiol 1984;53:17C-21C.
2. 2. Reeder GS, Bryant SC, Suman VJ, Holmes DR Jr. Intracoronary thrombus: still a risk factor for PTCA failure? Cathet Cardiovasc Diagn 1995;34:191-5.
3. 3. Kelsey SF, Miller DP, Holubkov R, Lu AS, Cowley MJ, Faxon DP, et al. Results of percutaneous transluminal coronary angioplasty in patients greater than or equal to 65 years of age (from the 1985 to 1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry). Am J Cardiol 1990;66:1033-8.
4. 4. Kern MJ, Deligonul U, Galan K, Zelman R, Gabliani G, Bell ST, et al. Percutaneous transluminal coronary angioplasty in octogenarians. Am J Cardiol 1988;61:457-8.
5. 5. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990;82:1193-202.
6. 6. Hermans WR, Foley DP, Rensing BJ, Rutsch W, Heyndrickx GR, Danchin N, et al. Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR study groups. Am J Cardiol 1993;72:14-20.
7. 7. Steffenino G, Meier B, Finci L, Velebit V, von Segesser L, Faidutti B, et al. Acute complications of elective coronary angioplasty: a review of 500 consecutive procedures. Br Heart J 1988;59:151-8.
8. 8. Cowley MJ, Dorros G, Kelsey SF, Van Raden M, Detre KM. Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol 1984;53:12C-16C.
9. 9. Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS Jr, King SB III, Gruentzig AR. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 1985;72:1044-52.
10. 10. Hannan EL, Arani DT, Johnson LW, Kemp HG Jr, Lukacik G. Percutaneous transluminal coronary angioplasty in New York state. Risk factors and outcomes. JAMA 1992;268:3092-7.
11. 11. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1988;12:529-45.
12. 12. Holmes DR Jr, Holubkov R, Vlietstra RE, Kelsey SF, Reeder GS, Dorros G, et al. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol 1988;12:1149-55.
13. 13. Richardson M, Pitney MR, Gibbons F, Cope GD, Cumpston GN, Mews GC. Short and long-term results of coronary angioplasty in patients over 75 years. Aust NZ J Med 1994;24:55-60.
14. 14. Savage MP, Goldberg S, Hirshfeld JW, Bass TA, MacDonald RG, Margolis JR, et al. Clinical and angiographic determinants of primary coronary angioplasty success. M-HEART Investigators. J Am Coll Cardiol 1991;17:22-8.
15. 15. Dorros G, Lewin RF, Mathiak LM. Percutaneous transluminal coronary angioplasty in multivessel coronary disease patients: short-and long-term follow-up in single and multiple dilatations. Clin Cardiol 1988;11:601-12.
16. 16. Ellis SG, Roubin GS, King SB III, Douglas JS Jr, Shaw RE, Stertzer SH, et al. In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8,207 procedures. J Am Coll Cardiol 1988;11:211-6.
17. 17. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
18. 18. The TIMI Study Group. Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932-6.
19. 19. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987;76:142-54.
20. 20. Hasselblad V. STATMAN. Duke Clinical Research Institute, Duke University, Durham, NC, 1996.
21. 21. Ellis SG, Elliott J, Hordgan M, Raymond R, Howell G. Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol 1996;78:642-6.
22. 22. Ferguson JJ, McDonough TJ, Worley SJ, French WJ, Corbelli JC, Blankenship JC, et al. Clinical outcome of "high-risk" vs "elective" patients undergoing percutaneous coronary intervention: results from IMPACT-II [abstract]. J Am Coll Cardiol 1996;27:180A.
23. 23. Loop FD, Golding LR, MacMillan JP, Cosgrove DM, Lytle BW, Sheldon WC. Coronary artery surgery in women compared with men: analyses of risks and long-term results. J Am Coll Cardiol 1983; 1:383-90.
24. 24. Fisher LD, Kennedy JW, Davis KB, Maynard C, Fritz JK, Kaiser G, et al. Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg 1982;84:334-41.
25. 25. Tyras DH, Bamer HB, Kaiser GC, Codd JE, Laks H, Willman VL. Myocardial revascularization in women. Ann Thorac Surg 1978; 25:449-53.
26. 26. Nwasokwa ON, Kass JH, Friedman GH, Grunwald AM, Bodenheimer MM. Bypass surgery for chronic stable angina: predictors of survival benefit and strategy for patient selection. Ann Intern Med 1991;114:1035-49.
27. 27. O'Connor N, Morton JR, Birkmeyer JD, Olmstead EM, O'Connor GT, for the Northern New England Cardiovascular Disease Study Group. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Circulation 1996;93:652-5.
28. 28. Lehmann KG, Foley DP, Melkert R, Keane D, Serruys PW. Physical stature and coronary size-a possible explanation for reduced infarctions in tall individuals [abstract]. Circulation 1994;90:1-109.
29. 29. Bergelson BA, Kyller MG, Jacobs AK, Ruocco NA, Ryan TJ, Faxon DP. Inadequacy of current criteria for predicting high risk coronary angioplasty [abstract]. J Am Coll Cardiol 1990;15:206A.
30. 30. Tenaglia AN, Fortin DF, Califf RM, Frid DJ, Nelson CL, Gardner L, et al. Predicting the risk of abrupt vessel closure after angioplasty in an individual patient. J Am Coll Cardiol 1994;24:1004-11.
31. 31. Popma JJ, Kennard E, Yeh W, Merritt AJ, Chuang YC, DeFalco RA, et al. Reproducibility of qualitative and quantitative angiographic findings in the New Approaches to Coronary Intervention (NACI) registry [abstract]. J Am Coll Cardiol 1995;Special Issue: 153A.
32. 32. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. Lancet 1994;343:881-6.